These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35530959)
21. RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m Ye J; Chen X; Jiang X; Dong Z; Hu S; Xiao M J Clin Lab Anal; 2022 Jul; 36(7):e24514. PubMed ID: 35689537 [TBL] [Abstract][Full Text] [Related]
22. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767 [TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine demethylase ALKBH5 homologous protein protects against cerebral I/R injury though suppressing SNHG3-mediated neural PANoptosis: Involvement of m6A-related macromolecules in the diseases of nervous system. Qiu Y; Fan Y; Huang G; Liu J Int J Biol Macromol; 2024 Aug; 274(Pt 2):133815. PubMed ID: 38996894 [TBL] [Abstract][Full Text] [Related]
24. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928 [TBL] [Abstract][Full Text] [Related]
25. ALKBH5 activates FAK signaling through m6A demethylation in Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222 [No Abstract] [Full Text] [Related]
26. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808 [TBL] [Abstract][Full Text] [Related]
27. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells. Luo J; Yu H; Yuan Z; Ye T; Hu B Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954 [TBL] [Abstract][Full Text] [Related]
28. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989 [TBL] [Abstract][Full Text] [Related]
29. ALKBH5 ALLEVIATES HYPOXIA POSTCONDITIONING INJURY IN d -GALACTOSE-INDUCED SENESCENT CARDIOMYOCYTES BY REGULATING STAT3. Zhang X; Li F; Ma J; Zhang X; Yin Y Shock; 2023 Jan; 59(1):91-98. PubMed ID: 36609501 [TBL] [Abstract][Full Text] [Related]
30. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466 [TBL] [Abstract][Full Text] [Related]
32. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis. Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329 [TBL] [Abstract][Full Text] [Related]
33. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation. Fan X; Wei C; Han Y Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of N6-methyladenosine-related RNA methylation in the mouse hippocampus after acquired hearing loss. Zhou X; Jin L; Li Y; Wang Y; Li W; Shen X BMC Genomics; 2023 Sep; 24(1):577. PubMed ID: 37759187 [TBL] [Abstract][Full Text] [Related]
35. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction. Gao X; Liang X; Liu B; Hong Y; He H; Shen Y; Chen J; Huang X; Hu B; Li W; Li X; Zhang Y FASEB J; 2023 Dec; 37(12):e23294. PubMed ID: 37966425 [TBL] [Abstract][Full Text] [Related]
37. m Liu Y; Zhou T; Wang Q; Fu R; Zhang Z; Chen N; Li Z; Gao G; Peng S; Yang D J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1210-1223. PubMed ID: 35142084 [TBL] [Abstract][Full Text] [Related]
38. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585 [TBL] [Abstract][Full Text] [Related]
39. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932 [TBL] [Abstract][Full Text] [Related]